Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| DYNAVAX TECHNOLOGIES CORP | 15,726,349 | reported | 22 Aug 2025 | tx 2−2,065,137 |
| LB PHARMACEUTICALS INC | 2,686,138 | reported | 12 Sept 2025 | tx 4+3,352,804−16,666,667 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Sept 2025 | CONVERSION | LB PHARMACEUTICALS INC | 686,138 | — | |
| 12 Sept 2025 | PURCHASE | LB PHARMACEUTICALS INC | 2,000,000 | 15.00 USD | |
| 12 Sept 2025 | PURCHASE | LB PHARMACEUTICALS INC | 666,666 | 15.00 USD | |
| 12 Sept 2025 | CONVERSION | LB PHARMACEUTICALS INC | 16,666,667 | — | deriv |
| 22 Aug 2025 | SALE | DYNAVAX TECHNOLOGIES CORP | 970,143 | 10.59 USD | |
| 21 Aug 2025 | SALE | DYNAVAX TECHNOLOGIES CORP | 1,094,994 | 11.03 USD |